Mark Damante, MD (@MarkD_Jr) header
Mark Damante, MD (@MarkD_Jr) profile picture
Joined October 2011
Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)Photo by Mark Damante, MD (@MarkD_Jr)
Mark Damante, MD retweeted
William Hunt was the Ohio State neurosurgeon who invented the Hunt-Hess grading scale for ruptured aneurysms/SAH & defined Tolosa-Hunt syndrome (painful inflammation of cavernous sinus). Honored to be the Hunt Visiting Professor at @NeurosurgeryOSU, and thrilled to see @BarrowNeuro graduates thriving here…
1
12
98
8,384
Mark Damante, MD retweeted
Join us in celebrating Russell R. Lonser, a CNS Past President, as our #2026CNS Founder’s Laurel Award recipient! One of the CNS’s highest honors, this award recognizing exceptional service, lifelong dedication, and meritorious accomplishments in medical education. Lonser’s longstanding leadership and commitment to advancing neurosurgical education exemplify the spirit of this award. Read more: bit.ly/4rHO7jW #CNSEvolution #neurosurgery @OSUWexMed
7
2
22
2,105
Mark Damante, MD retweeted
Friday was my last OR day @OSUWexMed @NeurosurgeryOSU *more emotional than I expected. I’m grateful for every patient who trusted us and for the colleagues who stood beside me through thousands of cases > 16y. I’ll carry this team and what we built together into my next chapter. – at Columbus, OH
7
10
1
133
8,207
A retrospective consortium study on targeted therapies for BRAF V600E mutant papillary craniopharyngioma showed that radiation-sparing, mono-therapeutic, and prolonged treatments are feasible. Read more at:link.springer.com/article/10…
6
10
987
Mark Damante, MD retweeted
Is age prognostic for lower grade IDH mutant glioma? NO, according to this pooled analysis In molecular era age alone should not influence decision-making adjuvant treatment Age is surrogate for IDH status ascopubs.org/doi/10.1200/JCO…
3
17
35
1,668
Six abstracts with two podiums @CNS_Update from the @NeurosurgeryOSU tumor and skull base research groups! All possible because of the great work from @MatthieuDWeber (MS4) and #RyanJuncker (MS2), and in collaboration with the @BarrowNeuro RAPID Consortium.
3
3
1
22
2,845
🧬Exciting work happening to advance more precise and reproducible delivery of gene therapies to the brain. 🧠 #genetherapy
New in @NeurosurgeryCNS: A systematic, image-guided method for convection-enhanced delivery of gene therapy to the bilateral thalami. Using intraoperative MR-imaging in patients with frontotemporal dementia across 3 international centers, the protocol produced consistent, reproducible thalamic coverage (Vd:Vi linear, R²=0.96). Standardizing the technique flattens the learning curve and drives scalability for deep brain gene therapy. @NeurosurgeryOSU @OSUWexMed @OSUGeneTherapy @AviadoBio #Neurosurgery #GeneTherapy #FTD #CED #Neuroscience ovid.com/10.1227/ons.0000000…
3
5
533
Mark Damante, MD retweeted
New in @NeurosurgeryCNS: A systematic, image-guided method for convection-enhanced delivery of gene therapy to the bilateral thalami. Using intraoperative MR-imaging in patients with frontotemporal dementia across 3 international centers, the protocol produced consistent, reproducible thalamic coverage (Vd:Vi linear, R²=0.96). Standardizing the technique flattens the learning curve and drives scalability for deep brain gene therapy. @NeurosurgeryOSU @OSUWexMed @OSUGeneTherapy @AviadoBio #Neurosurgery #GeneTherapy #FTD #CED #Neuroscience ovid.com/10.1227/ons.0000000…
3
2
14
3,242
Surgery for motor metastases pose functional risk that must be weighed against oncologic benefit. Resection preserved or improved function in the majority. Hemorrhage limited recovery, and both hemorrhage and persistent deficits predicted worse survival. ovid.com/jnls/neurosurgery/f…
1
4
4
1,098
Mark Damante, MD retweeted
Outstanding collaborative work published in Neurosurgery! Resection of motor gyrus metastases can improve neurological outcomes and survival, highlighting the importance of preserving and restoring function throughout the postoperative course. DOI: 10.1227/neu.0000000000004167
3
15
1,460
Mark Damante, MD retweeted
Dr. Miller presented the #NRG2026 Membership Updates including top accruing sites during the General Session. @dsmgyo 👏
3
2
9
853
A promising new drug therapy developed by #OSUWexMed neurosurgeon Dr. Shahid Nimjee may hold the key to providing effective treatment to stroke victims and solving one of the biggest complications in strokes: bleeding. health.osu.edu/discovery-and…
1
3
365
Mark Damante, MD retweeted
Just out in @TheJNS from Mark Damante, MD, (@MarkD_Jr ) and @NeurosurgeryOSU. CT-guided cranial #robotics were used to place multiple bilateral convective delivery cannulas in less than 30 min with sub-mm accuracy. This technique can be applied to a wide variety of convective perfusion therapies, including gene therapy. #Neurosurgery #CED #imaging #genetherapy thejns.org/view/journals/j-n… @OhioStateMed @OSUWexMed
3
1
15
2,025
⚽️ Great way to wrap up the Gene Therapy Symposium – Columbus Crew match with an incredible group. We’re already looking forward to next year.   #GeneTherapy
1
11
377
🧬 Today’s the day.   The 2nd Annual Gene Therapy Symposiumbegins this morning in Columbus. We’re excited to welcome researchers, clinicians, and industry leaders for two days of discussion, collaboration, and innovation in gene therapy.   #GeneTherapy #GenomicMedicine
2
1
6
1,036
Honored to have OSU neurosurgery alumnus, Dr. Peruzzi from @BWHNeurosurgery @harvardmed, as our visiting professor for our annual John McGregor, MD lectureship!
3
16
1,131
Great talk today by Dr. Brad Elder (@NeurosurgeryOSU) on CNS drug delivery, advantages of convective delivery of therapeutics, lessons learned from past clinical trials and exciting new trials using convective delivery for glioma.
3
8
633
🧬Program Highlight Columbus is emerging as a hub for #genetherapy innovation. At the 2nd Annual Gene Therapy Symposium, leaders from across academia, industry, and investment will discuss: "How Gene Therapy is Shaping the Biotech and Innovation Landscape in Columbus."
5
11
711